Research by Lambrechts and co‐workers showed that rs1051730 on chromosome 15q24/25 is associated with the presence and severity of emphysema and they discussed a shared pathogenic mechanism in COPD and lung cancer.22 As mentioned above, anti‐PD‐L1 antibody (e.g., atezolizumab) has revolutionized the treatment of NSCLC patients and has been approved in 201633 by the U.S. Food and Drug Administration. Here, CD274 is linked to lung carcinoma.